Echo Therapeutics, Inc. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)

Echo Therapeutics, Inc. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)

Echo Therapeutics, Inc. reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 112.00% for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-16.

Discontinued › Notes › Fair Value Measures and Disclosures

us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2016-11-16

• Echo Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2015-03-31 was 102.00%, a 15.70% decline year-over-year.
• Echo Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 121.00%, a 1.63% decline year-over-year.
• Echo Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 123.00%.
• Echo Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2015 was 89.00%, a 14.10% increase from fiscal 2014.
• Echo Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2014 was 78.00%, a 36.07% decline from fiscal 2013.
• Echo Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2013 was 122.00%, a 0.81% decline from fiscal 2012.
• Echo Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2012 was 123.00%, a 13.38% decline from fiscal 2011.